FDA Recall Alert: Children's Ibuprofen Products with Gel-like Mass and Black Particles
The FDA has issued a recall for children's ibuprofen due to complaints of a gel-like mass and black particles in the products. Strides Pharma, Inc. is recalling 89,592 bottles of Children’s Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottles that were distributed nationwide. The affected products have lot numbers 7261973A and 7261974A with an expiry date of Jan. 31, 2027. This recall has been classified as a Class II recall by the FDA, indicating that exposure to the product may lead to temporary or medically reversible adverse health consequences.
In response to complaints of a gel-like mass and black particles in children's ibuprofen products, the FDA has announced a recall of 89,592 bottles of Children’s Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottles distributed nationwide. The recalled products, manufactured for Taro Pharmaceuticals USA, Inc., have lot numbers 7261973A and 7261974A with an expiry date of Jan. 31, 2027. This recall has been classified as a Class II recall by the FDA, indicating that exposure to the product may lead to temporary or medically reversible adverse health consequences.
The FDA has issued a recall for children's ibuprofen products due to complaints of a gel-like mass and black particles in the medication. Strides Pharma, Inc. is recalling 89,592 bottles of Children’s Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottles that were distributed nationwide. The affected products have lot numbers 7261973A and 7261974A with an expiry date of Jan. 31, 2027. This recall has been classified as a Class II recall by the FDA, indicating that exposure to the product may lead to temporary or medically reversible adverse health consequences.
In response to complaints of a gel-like mass and black particles in children's ibuprofen products, the FDA has announced a recall of 89,592 bottles of Children’s Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottles distributed nationwide. The recalled products, manufactured for Taro Pharmaceuticals USA, Inc., have lot numbers 7261973A and 7261974A with an expiry date of Jan. 31, 2027. This recall has been classified as a Class II recall by the FDA, indicating that exposure to the product may lead to temporary or medically reversible adverse health consequences.
The FDA has issued a recall for children's ibuprofen products due to complaints of a gel-like mass and black particles in the medication. Strides Pharma, Inc. is recalling 89,592 bottles of Children’s Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottles that were distributed nationwide. The affected products have lot numbers 7261973A and 7261974A with an expiry date of Jan. 31, 2027. This recall has been classified as a Class II recall by the FDA, indicating that exposure to the product may lead to temporary or medically reversible adverse health consequences.
In conclusion, the FDA has issued a recall for children's ibuprofen products due to complaints of a gel-like mass and black particles in the medication. Strides Pharma, Inc. is recalling 89,592 bottles of Children’s Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottles that were distributed nationwide. The affected products have lot numbers 7261973A and 7261974A with an expiry date of Jan. 31, 2027. This recall has been classified as a Class II recall by the FDA, indicating that exposure to the product may lead to temporary or medically reversible adverse health consequences.